Company: PTPI
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001410578-25-001349
Chunk: 3

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part I, Item 1F
Chunk 3
---
 $0.0001 per share and $1,000 stated value), 1,000,000 and 0 shares authorized at March 31, 2025, and December 31, 2024, respectively, 0 and 0 shares issued and outstanding as of March 31, 2025, and December 31, 2024, respectively​​ —​​ —Common stock (par value $0.0001 per share, 250,000,000 and 250,000,000 shares authorized at March 31, 2025, and December 31, 2024, respectively; 2,052,762 and 421,124 shares issued and outstanding as of March 31, 2025, and December 31, 2024, respectively)​  205​ ​ 42​​​​​​​Additional paid-in capital​  105,883,980​ ​ 105,740,751Accumulated deficit​  (115,468,393)​ ​ (113,208,371)Total Stockholders’ Deficit​  (9,584,208)​ ​ (7,467,578)​​​​​​​Total Liabilities and Stockholders’ Deficit​$ 17,605,366​$ 10,635,310

​

The accompanying Notes are an integral part of the Unaudited Condensed Consolidated Financial Statements.

​